Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

Suzhou Highfine Biotech Revenue

Suzhou Highfine Biotech had revenue of 171.93M CNY in the quarter ending March 31, 2026, with 27.16% growth. This brings the company's revenue in the last twelve months to 638.98M, up 28.86% year-over-year. In the year 2025, Suzhou Highfine Biotech had annual revenue of 602.26M with 33.28% growth.

• Revenue (ttm): 638.98M
• Revenue Growth: +28.86%
• P/S Ratio: 10.76
• Revenue / Employee: 942.45K
• Employees: 678
• Market Cap: 6.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	602.26M	150.39M	33.28%
Dec 31, 2024	451.87M	63.08M	16.22%
Dec 31, 2023	388.79M	-58.66M	-13.11%
Jan 1, 2023	447.46M	78.02M	21.12%
Dec 31, 2021	369.44M	87.09M	30.85%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 24, 2026

Data Sources Report a data error